Physicians' Academy for Cardiovascular Education

Reviewing trials with P2Y12 blocker (mono)therapy after ACS

5' education - June 29, 2021 - Prof. Freek Verheugt, MD, PhD - Amsterdam, The Netherlands

Educational information

This video was recorded in response to a recent publication in Neth Heart J by Verheugt and colleagues.


Prof. Verheugt - cardioloog in Amsterdam, The Netherlands.


This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.

Find this article online at Neth Heart J

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Share this page with your colleagues and friends: